Bai YJ et al. |
[Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients]. |
2008 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:18845086
|
Pan ZX et al. |
[IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15555450
|
Naito T |
[Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. |
2010 |
Yakugaku Zasshi |
pmid:21139397
|
Fukudo M |
[Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis]. |
2007 |
Yakugaku Zasshi |
pmid:17603267
|
Sood S and Muthuraman A |
Activity of tacrolimus: an immunosuppressant, in pyloric ligation-induced peptic ulcer in the rat. |
2009 |
Yakugaku Zasshi |
pmid:19952532
|
Muraki Y |
[Factors affecting the pharmacokinetics after living donor liver transplant]. |
2012 |
Yakugaku Zasshi |
pmid:23023417
|
Iwamoto T et al. |
[Successful treatment by tacrolimus in two patients with Osserman's grade III intractable myasthenia gravis and elderly IIb]. |
2004 |
Yakugaku Zasshi |
pmid:15067188
|
Uchida K et al. |
Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. |
2010 |
Yakugaku Zasshi |
pmid:20046074
|
Shimizu K |
Development of New Liposome Targeting Strategies for Application of Disease Therapies. |
2017 |
Yakugaku Zasshi |
pmid:28049894
|
Tanaka Y et al. |
[Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. |
2013 |
Yakugaku Zasshi |
pmid:23328499
|